UK CLL Forum (2016) “Ibrutinib for relapsed/refractory chronic lymphocytic leukemia: a UK and Ireland analysis of outcomes in 315 patients”, Haematologica. Pavia, Italy, 101(12), pp. 1563-1572. doi: 10.3324/haematol.2016.147900.